Back to Search Start Over

CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury

Authors :
Yuki Sato
Akiko Oguchi
Yuji Fukushima
Kyoko Masuda
Naoya Toriu
Keisuke Taniguchi
Takahisa Yoshikawa
Xiaotong Cui
Makiko Kondo
Takeshi Hosoi
Shota Komidori
Yoko Shimizu
Harumi Fujita
Li Jiang
Yingyi Kong
Takashi Yamanashi
Jun Seita
Takuya Yamamoto
Shinya Toyokuni
Yoko Hamazaki
Masakazu Hattori
Yasunobu Yoshikai
Peter Boor
Jürgen Floege
Hiroshi Kawamoto
Yasuhiro Murakawa
Nagahiro Minato
Motoko Yanagita
Source :
The Journal of Clinical Investigation, Vol 132, Iss 2 (2022)
Publication Year :
2022
Publisher :
American Society for Clinical Investigation, 2022.

Abstract

Tertiary lymphoid tissues (TLTs) facilitate local T and B cell interactions in chronically inflamed organs. However, the cells and molecular pathways that govern TLT formation are poorly defined. Here, we identified TNF superfamily CD153/CD30 signaling between 2 unique age-dependent lymphocyte subpopulations, CD153+PD-1+CD4+ senescence-associated T (SAT) cells and CD30+T-bet+ age-associated B cells (ABCs), as a driver for TLT expansion. SAT cells, which produced ABC-inducing factors IL-21 and IFN-γ, and ABCs progressively accumulated within TLTs in aged kidneys after injury. Notably, in kidney injury models, CD153 or CD30 deficiency impaired functional SAT cell induction, which resulted in reduced ABC numbers and attenuated TLT formation with improved inflammation, fibrosis, and renal function. Attenuated TLT formation after transplantation of CD153-deficient bone marrow further supported the importance of CD153 in immune cells. Clonal analysis revealed that SAT cells and ABCs in the kidneys arose from both local differentiation and recruitment from the spleen. In the synovium of aged rheumatoid arthritis patients, T peripheral helper/T follicular helper cells and ABCs also expressed CD153 and CD30, respectively. Together, our data reveal a previously unappreciated function of CD153/CD30 signaling in TLT formation and propose targeting the CD153/CD30 signaling pathway as a therapeutic target for slowing kidney disease progression.

Subjects

Subjects :
Inflammation
Nephrology
Medicine

Details

Language :
English
ISSN :
15588238
Volume :
132
Issue :
2
Database :
Directory of Open Access Journals
Journal :
The Journal of Clinical Investigation
Publication Type :
Academic Journal
Accession number :
edsdoj.4e3ce5bb02bd4250838868a6955a71d3
Document Type :
article
Full Text :
https://doi.org/10.1172/JCI146071